Star Combo Ownership

S66 Stock   0.14  0.01  7.69%   
Star Combo Pharma shows a total of 135.08 Million outstanding shares. Star Combo Pharma has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 93.57 % of Star Combo outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Star Combo Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Star Stock Ownership Analysis

About 94.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Star Combo Pharma last dividend was issued on the 14th of October 2024. To find out more about Star Combo Pharma contact Su MBA at 61 2 9756 6555 or learn more at https://www.starcombo.com.au.

Star Combo Outstanding Bonds

Star Combo issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Star Combo Pharma uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Star bonds can be classified according to their maturity, which is the date when Star Combo Pharma has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Star Stock Analysis

When running Star Combo's price analysis, check to measure Star Combo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Star Combo is operating at the current time. Most of Star Combo's value examination focuses on studying past and present price action to predict the probability of Star Combo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Star Combo's price. Additionally, you may evaluate how the addition of Star Combo to your portfolios can decrease your overall portfolio volatility.